02 Nov
|
Allozymes
|
Prince Edward Island
02 Nov
Allozymes
Prince Edward Island
Shape biologics quality strategy, GMP readiness, and regulatory risk decisions across Agilent Therapeutic Division’s product portfolio. This senior executive role operates with significant autonomy.
The Director, Quality Science & Technology provides quality leadership for biological drug substances, reagents, and complex chemistry molecules. You will guide design, development, scale-up, technology transfer, commercialization, and post-market sustainment. Success requires influence across Product Development, Manufacturing, Regulatory Affairs, Supply Chain, Clients, and Global Quality.
Key Responsibilities: Establish science-based quality strategies for regulated product portfolios
Guide development protocols, specifications, validation, and GMP readiness
Assess changes through risk evaluation and impact assessment
Maintain the Quality Management System against applicable standards
Communicate quality metrics and regulatory insights to senior leadership
Requirements: Engineering, life sciences, or related bachelor’s degree required
Master’s or PhD preferred
10+ years supporting biological or pharmaceutical environments
Leadership experience in global, complex, matrixed organizations
ASQ certification or Six Sigma credentials preferred
Bring biologics quality leadership, GMP knowledge, and regulatory judgment to lifecycle decisions across Agilent’s therapeutic portfolio.
#J-18808-Ljbffr
📌 Biologics Quality Regulatory Director (Prince Edward Island)
🏢 Allozymes
📍 Prince Edward Island